Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
Please note the ANZCTR will be unattended on Monday the 7th of October for the Labour Day public holiday.
Additionally, the ANZCTR website will be unavailable from 1-3pm (AEST) on Thursday the 3rd of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12618001298202
Ethics application status
Approved
Date submitted
24/07/2018
Date registered
1/08/2018
Date last updated
3/12/2020
Date data sharing statement initially provided
23/07/2019
Type of registration
Prospectively registered
Titles & IDs
Public title
Allied health professional treatments for chronic nonspecific low back pain
Query!
Scientific title
Allied health professional treatments for chronic nonspecific low back pain
Query!
Secondary ID [1]
288569
0
None
Query!
Universal Trial Number (UTN)
U1111-1205-3767
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Chronic nonspecific low back pain
305522
0
Query!
Condition category
Condition code
Musculoskeletal
304764
304764
0
0
Query!
Other muscular and skeletal disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Participants will be fitted with full length prefabricated foot orthoses to wear in their usual shoes for 52 weeks. Participants will be encouraged at baseline to wear the orthoses as often as possible. Additionally, participants will also receive education about their low back pain in the form of the The Back Book. Participants will be instructed to read this booklet at home.
These interventions will be administered to participants once at the beginning of the trial by a qualified podiatrist. Participants will receive these interventions in a clinical setting.
Participants in this group will be given a diary so that they can record how many hours per day, over 12 weeks, they wear the prefabricated orthotic device. Intervention adhere after 12 weeks will not be monitored. At the 12 week follow-up, participants will be asked if they have read The Back Book.
Query!
Intervention code [1]
299639
0
Treatment: Devices
Query!
Comparator / control treatment
Participants will receive education about their low back pain in the form of the The Back Book. Participants will be instructed to read this booklet at home. At the 12 week follow-up, participants will be asked if they have read The Back Book.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
303988
0
Pain as assessed by a numeric pain rating scale.
Query!
Assessment method [1]
303988
0
Query!
Timepoint [1]
303988
0
Baseline, 12 weeks (primary time-point), 26 weeks, and 52 weeks after intervention commencement.
Query!
Primary outcome [2]
303989
0
Function as assessed by the Oswestry Disability Index.
Query!
Assessment method [2]
303989
0
Query!
Timepoint [2]
303989
0
Baseline, 12 weeks (primary time-point), 26 weeks and 52 weeks after intervention commencement.
Query!
Secondary outcome [1]
340658
0
Physical activity level as assessed by the International Physical Activity Questionnaire (short-7).
Query!
Assessment method [1]
340658
0
Query!
Timepoint [1]
340658
0
Baseline, 12 weeks, 26 weeks, and 52 weeks after intervention commencement.
Query!
Secondary outcome [2]
340659
0
Transversus abdominis muscle thickness as assessed by ultrasound.
Query!
Assessment method [2]
340659
0
Query!
Timepoint [2]
340659
0
Baseline and 12 weeks after intervention commencement.
Query!
Secondary outcome [3]
340660
0
Gluteus medius muscle activity as assessed by electromyography.
Query!
Assessment method [3]
340660
0
Query!
Timepoint [3]
340660
0
Baseline and 12 weeks after intervention commencement.
Query!
Secondary outcome [4]
349134
0
Number of hours foot orthotic worn as assessed by a self-reported diary provided at baseline.
Query!
Assessment method [4]
349134
0
Query!
Timepoint [4]
349134
0
12 weeks after intervention commencement.
Query!
Secondary outcome [5]
349135
0
Self reported adverse events associated with the intervention/s. Examples of known possible adverse events include: pain, discomfort, irritation, blister formation, and redness.
Query!
Assessment method [5]
349135
0
Query!
Timepoint [5]
349135
0
At any point from after intervention commencement to the end of the trial period (52 weeks).
Query!
Eligibility
Key inclusion criteria
Participants must have a history of chronic nonspecific low back pain (CNLBP) of three months or greater as confirmed by a general practitioner. The CNLBP will need to be located between the ribs and buttock creases to be eligible. Additionally, participants are required to be proficient in English and report a score of 3 or greater for their CNLBP on the Numeric Pain Rating Scale to ensure a minimally clinically important change for this score can be measured.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Participants will be excluded if they have non-mechanical low back pain (LBP) (e.g. spinal stenosis, spondylolisthesis, recent fractures, spinal surgery, tumours), specific LBP (e.g. herniated disc) acute or subacute LBP of any type, previous lower back surgery, neurological deficit, inflammatory joint disease, are pregnant or have previous (within the last 12 months) or current use of foot orthotic devices.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Sequentially numbered, sealed opaque envelopes
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Permuted block random allocation with mixed block lengths of four and six participants randomisation.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
The sample size for this trial was calculated to find minimal clinically important change of 2 (s=2.5) on the NPRS with 80% power, a 5% Type I error rate and non-adherence rate of 20%. NPRS was chosen for the calculation instead of the Oswestry disability index (ODI) because it had the smaller effect size and thus would require the larger sample size. The calculation adjusted for non-adherence required a total sample size of 30 per group, therefore a total of 60 participants will be recruited.
Statistical analysis will be conducted using the latest version of appropriate statistical software (SPSS or STATA). Analyses involving primary outcomes will be conducted on an intention-to-treat principle using all randomised participants. Missing data will be replaced using multiple imputation. Normality will be assessed using the Shapiro Wilks test. For the primary outcomes of pain and function (NPS and ODI), data will be compared using analysis of covariance (ANCOVA) to investigate the change from baseline to each of the follow-up points. The baseline measure will be the only covariate used in each analysis.
The IPAQ-7 will be used to determine changes in physical activity from baseline for participants using analysis of covariance at each time point (12, 26 and 52 weeks). The correlation between IPAQ score and change in primary outcomes will be investigated and where appropriate (significant correlations identified) a regression analysis performed.
For the secondary outcomes of GMed activity and TrA thickness, ANCOVA will be used to investigate change from baseline following the 12 week intervention for each variable. The baseline measure will be the only covariate used in each analysis.
Where appropriate, Cohen's d will used to calculate effect sizes for both primary and secondary outcomes.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
8/08/2018
Query!
Actual
11/09/2018
Query!
Date of last participant enrolment
Anticipated
15/12/2021
Query!
Actual
Query!
Date of last data collection
Anticipated
15/12/2022
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
41
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Funding & Sponsors
Funding source category [1]
298014
0
University
Query!
Name [1]
298014
0
University of Newcastle
Query!
Address [1]
298014
0
University Dr, Callaghan NSW 2308
Query!
Country [1]
298014
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of Newcastle
Query!
Address
University Dr, Callaghan NSW 2308
Query!
Country
Australia
Query!
Secondary sponsor category [1]
297086
0
None
Query!
Name [1]
297086
0
Query!
Address [1]
297086
0
Query!
Country [1]
297086
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
299050
0
The University of Newcastle Human Research Ethics Committee [EC00144]
Query!
Ethics committee address [1]
299050
0
University Drive, Callaghan, 2308, NSW
Query!
Ethics committee country [1]
299050
0
Australia
Query!
Date submitted for ethics approval [1]
299050
0
20/10/2017
Query!
Approval date [1]
299050
0
29/06/2018
Query!
Ethics approval number [1]
299050
0
Query!
Summary
Brief summary
Chronic nonspecific low back pain (CNLBP) has a significant impact on the health and well-being of individuals. The number of people with this condition is growing and the physical, mental, and financial costs are continuing to increase. People with CNLBP are more likely to experience changes to the way muscles in the hip and lower back area function. Foot orthoses have been shown to reduce pain and improve function in people with CNLBP. Additionally, foot orthotic devices have also been shown to alter the timing and intensity of muscle contractions in hip and lower back areas. This may be significant in the treatment of CNLBP as this condition is associated with dysfunction of muscles in these areas. The primary outcome measures will be change in pain and function from baseline to 12 (primary time point), 26, and 52 weeks. Secondary outcome measures include: gluteus medius muscle activity and transversus abdominis muscle thickness from baseline to 12 weeks, and physical activity over 12, 26, and 52 weeks. Number of hours per day and week that the prefabricated orthoses are worn over 12 weeks, as well as, adverse events over 52 weeks will be self-reported by participants.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
63650
0
A/Prof Vivienne Chuter
Query!
Address
63650
0
10 Chittaway Road
University of Newcastle
Ourimbah, NSW 2258
Query!
Country
63650
0
Australia
Query!
Phone
63650
0
+ 61 2 4349 4424
Query!
Fax
63650
0
Query!
Email
63650
0
vivienne.chuer@newcastle.edu.au
Query!
Contact person for public queries
Name
63651
0
Sean Sadler
Query!
Address
63651
0
10 Chittaway Road
University of Newcastle
Ourimbah, NSW 2258
Query!
Country
63651
0
Australia
Query!
Phone
63651
0
+61 2 4349 4655
Query!
Fax
63651
0
Query!
Email
63651
0
sean.sadler@newcastle.edu.au
Query!
Contact person for scientific queries
Name
63652
0
Vivienne Chuter
Query!
Address
63652
0
10 Chittaway Road
University of Newcastle
Ourimbah, NSW 2258
Query!
Country
63652
0
Australia
Query!
Phone
63652
0
+ 61 2 4349 4424
Query!
Fax
63652
0
Query!
Email
63652
0
vivienne.chuer@newcastle.edu.au
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Not necessary
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
3330
Study protocol
1. Sadler S, Spink M, Cassidy S, Chuter V: Prefabricated foot orthoses compared to a placebo intervention for the treatment of chronic nonspecific low back pain: a study protocol for a randomised controlled trial. Journal of foot and ankle research 2018, 11:56.
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF